Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2021First federal award
$5.0MFederal grants as PI5 awards
1Patents grantedLatest Jul 11, 2023
259Papers14,394 citations
Federal awards and patents by year
AwardsPatents
5 awards · $5.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 12, 2026 | NIH | SBIR Phase II Modulatory Role of Blood-Brain-Barrier and Enzymatic Activity in an Innovative Human Model of Anticholinergic Drug Induced Dementia | $1.5M | HESPEROS, INC |
| Aug 8, 2025 | NIH | SBIR Phase II Modulatory Role of Blood-Brain-Barrier and Enzymatic Activity in an Innovative Human Model of Anticholinergic Drug Induced Dementia | $1.5M | HESPEROS, INC |
| Aug 18, 2022 | NIH | SBIR Phase II Hesperos Diversity Supplement forgrant number 1 R44AG071386 | $163K | HESPEROS, INC |
| Aug 16, 2022 | NIH | SBIR Phase II Modulatory Role of Blood-Brain-Barrier and Enzymatic Activity in an Innovative Human Model of Cholinergic Drug Induced Dementia | $902K | HESPEROS, INC |
| Aug 10, 2021 | NIH | SBIR Phase II Modulatory Role of Blood-Brain-Barrier and Enzymatic Activity in an Innovative Human Model of Cholinergic Drug Induced Dementia | $902K | HESPEROS, INC |
2 patents as inventor
- US 11697795HESPEROS, INCJul 11, 2023
- US HESPEROS, INC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#284
Awards as PI#470
Patents#284
Companies
- HESPEROS, INCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.